AlphaSorb-C™ 1000 - 60 Tablets
Item#: 0725
Manufacturer SKU: 733739007254
- Threonic Acid & Alpha Lipoic Acid Enhanced
- Buffered, Bioavailable Vitamin C*
- A Dietary Supplement
- Vegetarian Formula
NOW® AlphaSorb-C™ includes Transport C-PLUS®, the trademarked blend of Threonic Acid Enhanced Buffered (non-acidic) Calcium Ascorbate and Alpha Lipoic Acid. Threonic Acid (a Vitamin C metabolite) has been shown to enhance cellular uptake of Vitamin C, Alpha Lipoic Acid is an antioxidant known to help regenerate Vitamin C in the body. Furthermore, studies suggest that Alpha Lipoic Acid may enhance the body's utilization of Vitamin C. The addition of Bioflavonoids as synergists helps to create a well-absorbed, highly effective Vitamin C supplement. Vitamin C is best known as a highly effective antioxidant that can protect the body's cells and molecules from damage by free radicals.*
Suggested Usage
As a dietary supplement, take 1 tablet daily, preferably with a meal. Consider taking this product in combination with NOW® Pycnogenol® and Advanced Gamma-E.
Serving Size
: 1 TabletServings Per Container
: 60| Amount Per Serving | % Daily Value* | |
| Vitamin C (from Threonic Acid Enhanced Buffered Calcium Ascorbate) | 1.0 g (1,000 mg) | 1667% |
| Calcium (from Buffered Calcium Ascorbate) | 120 mg | 12% |
|
Transport C-PLUS® (Trademarked blend of Threonic Acid Enhanced Buffered Calcium Ascorbate and Alpha Lipoic Acid) |
1.3 g (1,300 mg) | † |
| Alpha Lipoic Acid | 100 mg | † |
| Citrus Bioflavonoids (37% total bioflavonoids as Hesperidin) | 75 mg | † |
| Acerola Powder | 25 mg | † |
| Rose Hips Powder (Rosa canina) (Seed) | 25 mg | † |
| Rutin | 25 mg | † |
|
* Percent Daily Values are based on 2,000 calorie diet. † Daily Value not established. |
||
Other Ingredients:
Cellulose, Croscarmellose, Sodium, Stearic Acid (vegetable source), Silica, Magnesium Stearate (vegetable source) and Vegetable Coating. Vegetarian/Vegan Product.
Store in a cool, dry place. Please Recycle.
Transport C-PLUS® is a registered trademark of Helios Corp.
Patent Pending.
E-Newsletter sign-up
Facebook
Twitter